Restricting lipid accumulation in tumor-infiltrating neutrophils mediates caloric restriction-induced anti-cancer effects.
Gao. Jian J; Zhang. Wei W; Li. Qian Q; Zhao. Dan D; Cai. Jiayi J; Wang. Qing Q; Li. Xin X; Liu. Tingting T; Li. Jin J; Xiao. Wengan W; Li. Huimin H; Du. Min M; Zhang. Bing B; Li. Peiying P; Tu. Hong H; Gan. Yu Y
Key Findings
- Calorie restriction lowers IGF‑1 and HIF‑1α in neutrophils
- Reduced HIF‑1α decreases HILPDA, leading to less lipid buildup in tumor‑infiltrating neutrophils
- Less lipid transfer from neutrophils to tumors slows tumor growth and improves immune response
Practical Outcomes
- For biohackers, regular calorie restriction or intermittent fasting that lowers IGF‑1 may help curb cancer risk by altering neutrophil metabolism. Monitoring IGF‑1 levels could guide how strict a fasting protocol should be. Combining low‑IGF‑1 strategies with immunotherapy might enhance treatment outcomes.
Summary
Cutting calories lowers IGF‑1 levels, which then reduces a protein called HIF‑1α in neutrophils. This change stops neutrophils from storing fats, cutting the fuel tumors get and boosting the body’s anti‑cancer immunity. In mice, removing neutrophils wipes out the cancer‑fighting benefit of calorie restriction, showing neutrophils are key.
Abstract
Caloric restriction (CR) induces tumor resistance in mammals, but its mechanisms remain poorly understood. Here, we found that CR altered the proportions and gene expression profiles of tumor-infiltrating neutrophils (TINs). Depletion of neutrophils largely abrogated CR-induced tumor inhibition across multiple murine cancer models, underscoring their critical role in CR's broad anti-tumor effect. CR-induced gene expression changes in TINs were associated primarily with lipid-related processes, notably downregulating hypoxia-inducible lipid droplet-associated (HILPDA). This downregulation reduced lipid accumulation in TINs, limiting tumor growth and enhancing anti-tumor immunity by decreasing lipid transfer to tumor and immune effector cells. Upstream, CR reduced hypoxia-inducible factor 1 (HIF-1α) mRNA expression in circulating neutrophils by decreasing insulin-like growth factor 1 (IGF-1), thereby limiting HILPDA expression in TINs. Patients with lung cancer who had low baseline neutrophil HIF-1α mRNA exhibited improved responses to combined immunotherapy. These findings identify a novel neutrophil- and lipid-centered mechanism for CR-induced tumor inhibition, suggesting the IGF-1/HIF-1α/HILPDA axis as a therapeutic target.
Study Information
pubmed
2025
2025-12-05T00:00:00.000Z
10.1016/j.cmet.2025.11.007
77